Table 2 Comorbid conditions and Beck anxiety and depression scores for study patients
Group A (n = 18) | Group B (n = 22) | p-value | |
|---|---|---|---|
DM | 1 (5.6%) | 9 (40.9%) | 0.01* |
HTN | 5 (27.8%) | 8 (36.40%) | 0.40 |
GERD | 11 (61.1%) | 20 (90.9%) | 0.03* |
Allergic rhino-sinusitis | 9 (50%) | 9 (40.9%) | 0.39 |
OSA | 1 (5.6%) | 9 (40.9%) | 0.01* |
Food allergy | 1 (5.6%) | 14 (63.6%) | <0.001* |
Oral steroids | 0 | 9 (40.9%) | <0.001* |
Inadequate ICS | 9 (50%) | 10 (45.5%) | 0.51 |
SABA overuse | 2 (11.1%) | 17 (77.3%) | <0.001* |
Asthma control level | |||
Controlled Partly-controlled Un-controlled | 13 (72.2%) 3 (16.7%) 2 (11.1%) | 1 (4.5%) 1 (4.5%) 20 (90.9%) | <0.001* |
Asthma adherence score | |||
Low Medium High | 4 (22.2%) 4 (22.2%) 10 (55.6%) | 12 (54.5%) 6 (27.3%) 4 (18.2%) | <0.03* |
BAI | |||
Low Moderate High level | 12 (66.7%) 4 (22.2%) 2 (11.1%) | 2 (9.1%) 10 (45.5%) 10 (45.5%) | <0.001* |
BDI-II | |||
Normal Borderline Mild Moderate Severe | 3 (16.7%) 10 (16.7%) 4 (22.2%) 1 (5.6%) 0 | 0 0 9 (40.9%) 11 (50%) 2 (9.1%) | <0.001* |